Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

To identify genetic factors contributing to vitamin D and BMD measures, association analysis of >14M variants was conducted in a maximum of 697 African American-Diabetes Heart Study participants with type 2 diabetes (T2D).

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

DNA from AA-DHS participants was extracted from peripheral blood using the PureGene system (Gentra Systems, Minneapolis, MN).

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Genome-wide association study of vitamin D concentrations and bone mineral density in the African American-Diabetes Heart Study

Study design awaiting verification · PLoS ONE · 2021

Original publication title

Genome-wide association study of vitamin D concentrations and bone mineral density in the African American-Diabetes Heart Study

Nicholette D. Palmer; Lingyi Lu; Thomas C. Register; Leon Lenchik; J. Jeffrey Carr; Pamela J. Hicks; S. Carrie Smith; Jianzhao Xu; Latchezar Dimitrov; Jacob Keaton; Meijian Guan; Maggie C. Y. Ng; Yii-der I. Chen; Anthony J. Hanley; Corinne D. Engelman; Jill M. Norris; Carl D. Langefeld; Lynne E. Wagenknecht; Donald W. Bowden; Barry I. Freedman; Jasmin Divers

© 2021 Palmer et al

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Relative to European Americans, African Americans have lower 25-hydroxyvitamin D (25OHD) and vitamin D binding protein (VDBP) concentrations, higher 1,25-dihydroxyvitamin D (1,25(OH)2D3) concentrations and bone mineral density (BMD), and paradoxically reduced burdens of calcified atherosclerotic plaque (subclinical atherosclerosis). To identify genetic factors contributing to vitamin D and BMD measures, association analysis of >14M variants was conducted in a maximum of 697 African American-Diabetes Heart Study participants with type 2 diabetes (T2D). The most significant association signals were detected for VDBP on chromosome 4; variants rs7041 (β = 0.44, SE = 0.019, P = 9.4x10-86) and rs4588 (β = 0.17, SE = 0.021, P = 3.5x10-08) in the group-specific component (vitamin D binding protein) gene (GC).

These variants were found to be independently associated. In addition, rs7041 was also associated with bioavailable vitamin D (BAVD; β = 0.16, SE = 0.02, P = 3.3x10-19). Six rare variants were significantly associated with 25OHD, including a non-synonymous variant in HSPG2 (rs116788687; β = -1.07, SE = 0.17, P = 2.2x10-10) and an intronic variant in TNIK (rs143555701; β = -1.01, SE = 0.18, P = 9.0x10-10), both biologically related to bone development.

Variants associated with 25OHD failed to replicate in African Americans from the Insulin Resistance Atherosclerosis Family Study (IRASFS). Evaluation of vitamin D metabolism and bone mineral density phenotypes in an African American population enriched for T2D could provide insight into ethnic specific differences in vitamin D metabolism and bone mineral density.

Authors’ abstract

Relative to European Americans, African Americans have lower 25-hydroxyvitamin D (25OHD) and vitamin D binding protein (VDBP) concentrations, higher 1,25-dihydroxyvitamin D (1,25(OH)2D3) concentrations and bone mineral density (BMD), and paradoxically reduced burdens of calcified atherosclerotic plaque (subclinical atherosclerosis). To identify genetic factors contributing to vitamin D and BMD measures, association analysis of >14M variants was conducted in a maximum of 697 African American-Diabetes Heart Study participants with type 2 diabetes (T2D). The most significant association signals were detected for VDBP on chromosome 4; variants rs7041 (β = 0.44, SE = 0.019, P = 9.4x10-86) and rs4588 (β = 0.17, SE = 0.021, P = 3.5x10-08) in the group-specific component (vitamin D binding protein) gene (GC).

These variants were found to be independently associated. In addition, rs7041 was also associated with bioavailable vitamin D (BAVD; β = 0.16, SE = 0.02, P = 3.3x10-19). Six rare variants were significantly associated with 25OHD, including a non-synonymous variant in HSPG2 (rs116788687; β = -1.07, SE = 0.17, P = 2.2x10-10) and an intronic variant in TNIK (rs143555701; β = -1.01, SE = 0.18, P = 9.0x10-10), both biologically related to bone development.

Variants associated with 25OHD failed to replicate in African Americans from the Insulin Resistance Atherosclerosis Family Study (IRASFS). Evaluation of vitamin D metabolism and bone mineral density phenotypes in an African American population enriched for T2D could provide insight into ethnic specific differences in vitamin D metabolism and bone mineral density.

Publication and source details

Original title: Genome-wide association study of vitamin D concentrations and bone mineral density in the African American-Diabetes Heart Study

Nicholette D. Palmer; Lingyi Lu; Thomas C. Register; Leon Lenchik; J. Jeffrey Carr; Pamela J. Hicks; S. Carrie Smith; Jianzhao Xu; Latchezar Dimitrov; Jacob Keaton; Meijian Guan; Maggie C. Y. Ng; Yii-der I. Chen; Anthony J. Hanley; Corinne D. Engelman; Jill M. Norris; Carl D. Langefeld; Lynne E. Wagenknecht; Donald W. Bowden; Barry I. Freedman; Jasmin Divers

PLoS ONE · 2021

Competing Interests: The authors have declared that no competing interests exist.

* E-mail: nallred@wakehealth.edu (NDP); bfreedma@wakehealth.edu (BIF)
© 2021 Palmer et al2021Palmer et alhttps://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.National Institute on Aging (US)AG058921https://orcid.org/0000-0001-8883-2511Palmer Nicholette D. http://dx.doi.org/10.13039/100000062National Institute of Diabetes and Digestive and Kidney DiseasesDK071891Freedman Barry I. http://dx.doi.org/10.13039/100000050National Heart, Lung, and Blood InstituteAR48797Carr J. Jeffrey http://dx.doi.org/10.13039/100000050National Heart, Lung, and Blood InstituteHL67348Bowden Donald W. This project was supported by NIH R01 AG058921 (NDA), NIH R01 DK071891 (BIF), NIH R01 AR48797 (JJC), NIH R01 HL67348 (DWB), NIH R01 AG058921 (NDA) and NIH P20MD006899 (SGB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T13:29:21.992909+00:00

DOI: 10.1371/journal.pone.0251423 · PMC8136717